Thu 19 Nov 2026 20:14:01 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

Information Messages
  • The WDA has been withdrawn, withdrawn date is: 2025-10-01
  • RTF Template


    Norwegian Medical Products Agency

    UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION

    Human medicinal products


    1. Authorisation Number

    :

    25/07911-2

    2. Name of Authorisation Holder

    :

    Air Liquide Norway AS

    (ORG-100017358 / LOC-100058234)

    3. Address(es) of Site(s)

    :

    Drammensveien 64b, Mjoendalen, Viken, 3050, Norway 




    4. Legally registered address of Authorisation Holder

    :

    Drammensveien 64b, Mjoendalen, Viken, 3050

    5. Scope of authorisation

    :

    ANNEX 1

    6. Legal basis of authorisation

    :

    Art. 77(1) of Directive 2001/83/EC

    7. Name of responsible officer of the competent authority of the member state granting the wholesale distribution authorisation

    :

    Confidential, Confidential

    8. Signature

    :


    9. Date

    :

    2025-06-23

    10. Annexes attached

    :

    Annex 1 Scope of wholesale distribution authorisation

    Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

    Annex 3 (Optional) Name(s) of responsible person(s)

    Annex 4 (Optional) Date of Inspection on which authorisation was granted

    Annex 5 (Optional) Additional provisions based on national requirements


    ANNEX 1

    SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



    Name and address of the site: Air Liquide Norway AS

    (ORG-100017358 / LOC-100058234)

    , Drammensveien 64b, Mjoendalen, Viken, 3050, Norway   



    Human medicinal products


    1. MEDICINAL PRODUCTS

       1.1. with a Marketing Authorisation or registration in EEA country(s)


    2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

       2.1. Procurement 

       2.2. Holding 

       2.3. Supply 

       2.4. Export 

       2.5. Other activities(s): (please specify) Direct distribution to professional end-users, cf. the Norwegian Act on Medicinal Products. etc.Direktedistribusjon til profesjonelle sluttbrukere, jf. legemiddelloven §15 og grossistforskriften.


    3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

       3.3. Other products: (please specify here or make a reference to Annex 5) Medicinal gases Medisinske gasser




    Any restrictions or clarifying remarks (for all users):  Section 2.5 grants the right to perform direct distribution to a professional end user of the medicinal products
    covered by the authorization:
    - To nursing homes, cf. the Regulation of 21 December 1993 relating to the Distribution of Medicinal Products § 13 first section point 4 and § 14.
    - To hospitals and other prescribers of medicinal gases, cf. the Regulation of 21 December 1993 relating to the Distribution of Medicinal Products § 13 second section.
    Direct distribution should be performed according to Regulations of 2 June 2022 on prescribing and delivery of medicinal products from pharmacies, which demand control by a pharmacist of requisitions and dispensing of medicines.

    Avsnitt 2.5 gir rett til direktedistribusjon av de legemidlene som er dekket av tillatelsen:
    - til sykehjem, jf. Forskrift av 21. desember 1993 om grossistvirksomhet med legemidler § 13 første ledd punkt 4 og § 14.
    - til sykehus og øvrige rekvirenter, jf. Forskrift av 21. desember 1993 om grossistvirksomhet med legemidler § 13 andre ledd.

    Utlevering skal utføres i henhold til 2. juni 2022 om rekvirering og utlevering av legemidler mm. (heretter utleveringsforskriften) med krav om farmasøytkontroll av rekvisisjon.








    Reason for Withdrawing:

    Replaced by an updated version








    Union Format for a Wholesale Distribution Authorisation

    25/07911-2


    Page 1





    Loading, please wait